Skip to main content
EN
Caution:
At present, there are occasional discrepancies in the display of intellectual property rights holders and their representatives. We are working on a solution.
Patent Search
Details
Details for 2011775734
Up to date per 10.06.2026
Actions
Copy link to European Patent
Download Registration Print
Details
Details for 2011775734
Title / Product Name
ZELLDURCHLÄSSIGER PEPTIDHEMMER DES JNK-SIGNALTRANSDUKTIONSWEGES ZUR VERWENDUNG IN DER BEHANDLUNG VON UVEITIS
Status
Deleted
Protection Type
European Patent
(AT-) Application Number
2011775734
EP Publication Number
2627346
E-Number
782470
Language
EN
PCT Number
EP11005172
Publication Date
21.08.2013 A
23.03.2016 B1
Registration Date
23.03.2016
AT Publication Date
15.04.2016
Application Date
14.10.2011
Registration Number
-
Priorities
25.01.2011
WO
PCT/EP2011/000307
14.10.2010
WO
PCT/EP2010/006284
IPC
A61K 38/00 20060101AFI20120503BHEP
Maximum Duration of Protection
14.10.2031
Owner
Xigen Inflammation Ltd.
Arch. Makariou III 195 Neocleous House
3030 Limassol
CY
Representative
Representative
Christoph Maschler
Innsbruck
Inventor
COMBETTE, Jean-Marc
515, route de Terret
F-74140 Saint-Cergues
FR
DELOCHE, Catherine
22, Avenue William-Favre
CH-1207 Genf
CH
ABADIE, Claire
8 rue des Francs-Tireurs
F-74000 Annecy
FR
see.ip - Details for ZELLDURCHLÄSSIGER PEPTIDHEMMER DES JNK-SIGNALTRANSDUKTIONSWEGES ZUR VERWENDUNG IN DER BEHANDLUNG VON UVEITIS